Drug Safety Labeling Changes - May 2012

Creator: Madhumathi Palaniappan
Keywords: FDA label changes May - 2012, Drug Name, Sections Modified, Contraindications, Precautions, Adverse Reactions

Written & Compiled by - Madhumathi Palaniappan

Medically Reviewed by - The Medindia Medical Review Team

Food and Drug Administration (FDA) announces important safety label changes for prescription drugs almost every month. By implementing the label changes the FDA warns a physician of new side- effects, adverse reactions, contra-indications and precautions necessary for a drug. This information is important for safe practice of medicine.

Key to Label Sections

C - Contraindications
W - Warnings
P - Precautions
AR - Adverse Reactions

Drug Name	Sections Modified
Drug Name	C	W	P	AR
Abobotulinumtoxin A Injection	-	-	-	-
Adalimumab	-	-	-
Albuterol and Ipratropium	-	-	-
Alefacept	-	-	-
Benazepril	-
Bevacizumab	-	-	-
Chlorascrub Swabsticks	-		-	-
Chlorhexidine	-		-	-
Chlorhexidine	-		-	-
Chlorhexidine	-		-	-
Clarithromycin	-			-
Clonidine	-			-
Daptomycin	-	-		-
Denosumab	-	-		-
Dexlansoprazole	-			-
Dexmethylphenidate hcl		-	-
Estradiol				-
Ethosuximide	-
Filgrastim	-	-	-
Fingolimod
Insulin Detemir	-	-
Iopromide	-
Iopromide	-	-	-	-
Lansoprazole	-			-
Lenalidomide	-	-	-	-
Linagliptin	-	-
Lisinopril	-	-	-
Lisinopril and Hydrochlorothiazide	-	-	-
Omeprazole and Sodium Bicarbonate	-			-
Pamidronate	-
Pantoprazole	-			-
Pioglitazone and Metformin	-
Pralatrexate Solution	-
Rabeprazole	-			-
Ulipristal Acetate	-	-		-
Ustekinumab	-	-
Venlafaxine	-	-		-